SCHEMBL6203784

SCHEMBL6203784

CCC(C(=O)NCc1nccs1)N(c1ccccc1OC)S(=O)(=O)c1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ PTGER1 P34995 1/20 0.39
▸ PDE10A Q9Y233 1/20 0.38
▸ NPC1 O15118 2/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ USP2 O75604 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ PKM P14618 1/20 0.36
▸ REN P00797 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183808 0.84 HCRTR2 (0.42) MEN1KMT2A
SCHEMBL1076164 0.82 ALDH1A1 (0.54) NPC1KMT2APKM
SCHEMBL1078296 0.80 PTGER1 (0.44) HPGDPTGER1LMNAMEN1KMT2A
SCHEMBL6199052 0.79 HIF1A (0.42) PTGER1PDE10ALMNAMEN1KMT2A
SCHEMBL1078008 0.79 KMT2A (0.43) HPGDPTGER1NPC1RAB9AMEN1
SCHEMBL1078165 0.79 PTGER1 (0.43) HPGDPTGER1RAB9ALMNA
SCHEMBL1074513 0.79 PTGER1 (0.44) PTGER1LMNAMEN1KMT2A
SCHEMBL6185927 0.75 HPGD (0.43) HPGDRAB9AMEN1KMT2APKM
SCHEMBL1039050 0.74 HCRTR2 (0.52) PTGER1MEN1KMT2ANPSR1
SCHEMBL1076948 0.69 HCRTR1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554239-A2 SULFONYLAMINO-ACETIC ACID DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-07-20 — — EP disclosed
WO-2004033418-A2 SULFONYLAMINO-ACETIC DERIVATIVES AND THEIR USE AS OREXIN RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD. (CH) 2004-04-22 — — WO disclosed
Send feedback